Plozalizumab (MLN-1202) is a humanized selective and potent anti-CCR2 antibody.Plozalizumab has antitumor activity.Plozalizumab is used in the study of malignant melanoma.
CAS Number:
[1610761-46-0]
Target:
MLN-1202
* VAT and and shipping costs not included. Errors and price changes excepted